The Drug Regulatory Authority of Pakistan (Drap) said on Monday that Remdesivir, an effective anti-COVID 19 drug, will be available in the country within three weeks. Drap, after registration of the medicine, had allowed two pharmaceutical companies to import this critical drug. The regulator has given licences to 14 manufacturers for producing the medicine at home.